메뉴 건너뛰기




Volumn 7, Issue 3, 2013, Pages 480-490

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin

Author keywords

Hemagglutinin; Monoclonal antibody; Protective epitopes

Indexed keywords

EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ;

EID: 84876495377     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12029     Document Type: Article
Times cited : (17)

References (40)
  • 1
    • 67449110743 scopus 로고    scopus 로고
    • Emergence of a novel swine-origin influenza A (H1N1) virus in humans
    • Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
    • (2009) N Engl J Med , vol.360 , pp. 2605-2615
    • Dawood, F.S.1    Jain, S.2    Finelli, L.3
  • 2
    • 67449152290 scopus 로고    scopus 로고
    • Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009
    • Shinde V, Bridges CB, Uyeki TM et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009; 360:2616-2625.
    • (2009) N Engl J Med , vol.360 , pp. 2616-2625
    • Shinde, V.1    Bridges, C.B.2    Uyeki, T.M.3
  • 3
    • 67650407532 scopus 로고    scopus 로고
    • Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans
    • Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
    • (2009) Science , vol.325 , pp. 197-201
    • Garten, R.J.1    Davis, C.T.2    Russell, C.A.3
  • 4
    • 67649538978 scopus 로고    scopus 로고
    • Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic
    • Smith GJ, Vijaykrishna D, Bahl J et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009; 459:1122-1125.
    • (2009) Nature , vol.459 , pp. 1122-1125
    • Smith, G.J.1    Vijaykrishna, D.2    Bahl, J.3
  • 5
    • 33751247050 scopus 로고    scopus 로고
    • Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States
    • Vincent AL, Lager KM, Ma W et al. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet Microbiol 2006; 4:212-222.
    • (2006) Vet Microbiol , vol.4 , pp. 212-222
    • Vincent, A.L.1    Lager, K.M.2    Ma, W.3
  • 6
    • 70349873173 scopus 로고    scopus 로고
    • Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus
    • Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
    • (2009) N Engl J Med , vol.361 , pp. 1945-1952
    • Hancock, K.1    Veguilla, V.2    Lu, X.3
  • 7
    • 0033986874 scopus 로고    scopus 로고
    • Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells
    • LaBoissiere S, O'Hare P. Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells. J Virol 2000; 74:99-109.
    • (2000) J Virol , vol.74 , pp. 99-109
    • LaBoissiere, S.1    O'Hare, P.2
  • 8
    • 77951825335 scopus 로고    scopus 로고
    • Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus
    • McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis 2010; 50:1487-1492.
    • (2010) Clin Infect Dis , vol.50 , pp. 1487-1492
    • McCullers, J.A.1    Van De Velde, L.A.2    Allison, K.J.3    Branum, K.C.4    Webby, R.J.5    Flynn, P.M.6
  • 9
    • 81855173722 scopus 로고    scopus 로고
    • Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice
    • Xie H, Li X, Gao J et al. Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice. Clin Infect Dis 2011; 53:1179-1187.
    • (2011) Clin Infect Dis , vol.53 , pp. 1179-1187
    • Xie, H.1    Li, X.2    Gao, J.3
  • 10
    • 79959842089 scopus 로고    scopus 로고
    • Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2
    • Wang W, Anderson CM, De Feo CJ et al. Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. PLoS Pathog 2011;7:e1002081.
    • (2011) PLoS Pathog , vol.7
    • Wang, W.1    Anderson, C.M.2    De Feo, C.J.3
  • 11
    • 79954632010 scopus 로고    scopus 로고
    • Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets
    • Ellebedy AH, Ducatez MF, Duan S et al. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. Vaccine 2011; 29:3335-3339.
    • (2011) Vaccine , vol.29 , pp. 3335-3339
    • Ellebedy, A.H.1    Ducatez, M.F.2    Duan, S.3
  • 12
  • 13
    • 77649216411 scopus 로고    scopus 로고
    • Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines
    • Manicassamy B, Medina RA, Hai R et al. Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 2010; 6:e1000745.
    • (2010) PLoS Pathog , vol.6
    • Manicassamy, B.1    Medina, R.A.2    Hai, R.3
  • 14
    • 77956194316 scopus 로고    scopus 로고
    • Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay
    • Labrosse B, Tourdjman M, Porcher R et al. Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay. PLoS ONE 2010; 5:e11036.
    • (2010) PLoS ONE , vol.5
    • Labrosse, B.1    Tourdjman, M.2    Porcher, R.3
  • 15
    • 73049100357 scopus 로고    scopus 로고
    • Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
    • Plennevaux E, Sheldon E, Blatter M, Reeves-Hoche MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375:41-48.
    • (2010) Lancet , vol.375 , pp. 41-48
    • Plennevaux, E.1    Sheldon, E.2    Blatter, M.3    Reeves-Hoche, M.K.4    Denis, M.5
  • 16
    • 77956886544 scopus 로고    scopus 로고
    • Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains
    • Lee VJ, Tay JK, Chen MI et al. Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains. Vaccine 2010; 28:6852-6857.
    • (2010) Vaccine , vol.28 , pp. 6852-6857
    • Lee, V.J.1    Tay, J.K.2    Chen, M.I.3
  • 17
    • 79551644116 scopus 로고    scopus 로고
    • Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly
    • Xie H, Jing X, Li X et al. Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS ONE 2011; 6:e16650.
    • (2011) PLoS ONE , vol.6
    • Xie, H.1    Jing, X.2    Li, X.3
  • 18
    • 84859836264 scopus 로고    scopus 로고
    • Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase
    • Schmeisser F, Adamo JE, Blumberg B et al. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase. Vaccine 2012; 30:3413-3422.
    • (2012) Vaccine , vol.30 , pp. 3413-3422
    • Schmeisser, F.1    Adamo, J.E.2    Blumberg, B.3
  • 19
    • 77249116168 scopus 로고    scopus 로고
    • An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination
    • Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Vaccine 2010; 28:2442-2449.
    • (2010) Vaccine , vol.28 , pp. 2442-2449
    • Schmeisser, F.1    Vodeiko, G.M.2    Lugovtsev, V.Y.3    Stout, R.R.4    Weir, J.P.5
  • 20
    • 85024841426 scopus 로고    scopus 로고
    • Preparation of cell cultures and vaccinia virus stocks
    • in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith J (eds): . New York: John Wiley and Sons, Inc.
    • Earl P, Cooper N, Wyatt L, Moss B, Carroll M. Preparation of cell cultures and vaccinia virus stocks; in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith J et al. (eds): Current Protocols in Molecular Biology. New York: John Wiley and Sons, Inc., 1998; 16.16.1-16.16.13.
    • (1998) Current Protocols in Molecular Biology , pp. 16161-161613
    • Earl, P.1    Cooper, N.2    Wyatt, L.3    Moss, B.4    Carroll, M.5
  • 22
    • 0033041241 scopus 로고    scopus 로고
    • Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays
    • Rowe T, Abernathy RA, Hu-Primmer J et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37:937-943.
    • (1999) J Clin Microbiol , vol.37 , pp. 937-943
    • Rowe, T.1    Abernathy, R.A.2    Hu-Primmer, J.3
  • 23
    • 77957688042 scopus 로고    scopus 로고
    • A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity
    • Wang W, Castelan-Vega JA, Jimenez-Alberto A, Vassell R, Ye Z, Weiss CD. A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity. Virology 2010; 407:374-380.
    • (2010) Virology , vol.407 , pp. 374-380
    • Wang, W.1    Castelan-Vega, J.A.2    Jimenez-Alberto, A.3    Vassell, R.4    Ye, Z.5    Weiss, C.D.6
  • 24
    • 53049089447 scopus 로고    scopus 로고
    • Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies
    • Wang W, Butler EN, Veguilla V et al. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods 2008; 153:111-119.
    • (2008) J Virol Methods , vol.153 , pp. 111-119
    • Wang, W.1    Butler, E.N.2    Veguilla, V.3
  • 25
    • 77951023285 scopus 로고    scopus 로고
    • Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays
    • Wang W, Xie H, Ye Z, Vassell R, Weiss CD. Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays. J Virol Methods 2010; 165:305-310.
    • (2010) J Virol Methods , vol.165 , pp. 305-310
    • Wang, W.1    Xie, H.2    Ye, Z.3    Vassell, R.4    Weiss, C.D.5
  • 26
    • 0018152058 scopus 로고
    • Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies
    • Gerhard W, Webster RG. Antigenic drift in influenza A viruses. I. Selection and characterization of antigenic variants of A/PR/8/34 (HON1) influenza virus with monoclonal antibodies. J Exp Med 1978; 148:383-392.
    • (1978) J Exp Med , vol.148 , pp. 383-392
    • Gerhard, W.1    Webster, R.G.2
  • 27
    • 77951165843 scopus 로고    scopus 로고
    • Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus
    • Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 2010; 328:357-360.
    • (2010) Science , vol.328 , pp. 357-360
    • Xu, R.1    Ekiert, D.C.2    Krause, J.C.3    Hai, R.4    Crowe Jr., J.E.5    Wilson, I.A.6
  • 29
    • 84862908804 scopus 로고    scopus 로고
    • Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies
    • Terajima M, Cruz J, Co MD et al. Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies. J Virol 2012; 85:13463-13467.
    • (2012) J Virol , vol.85 , pp. 13463-13467
    • Terajima, M.1    Cruz, J.2    Co, M.D.3
  • 30
    • 0020680927 scopus 로고
    • Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement
    • Beebe DP, Schreiber RD, Cooper NR. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement. J Immunol 1983; 130:1317-1322.
    • (1983) J Immunol , vol.130 , pp. 1317-1322
    • Beebe, D.P.1    Schreiber, R.D.2    Cooper, N.R.3
  • 31
    • 0015444824 scopus 로고
    • Enhancement of hemagglutination inhibition by complement
    • Reno PW, Hoffmann EM. Enhancement of hemagglutination inhibition by complement. Infect Immun 1972; 6:945-951.
    • (1972) Infect Immun , vol.6 , pp. 945-951
    • Reno, P.W.1    Hoffmann, E.M.2
  • 32
    • 0036145303 scopus 로고    scopus 로고
    • Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype
    • Feng JQ, Mozdzanowska K, Gerhard W. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J Virol 2002; 76:1369-1378.
    • (2002) J Virol , vol.76 , pp. 1369-1378
    • Feng, J.Q.1    Mozdzanowska, K.2    Gerhard, W.3
  • 33
    • 33747036652 scopus 로고    scopus 로고
    • Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components
    • Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W. Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology 2006; 352:418-426.
    • (2006) Virology , vol.352 , pp. 418-426
    • Mozdzanowska, K.1    Feng, J.2    Eid, M.3    Zharikova, D.4    Gerhard, W.5
  • 34
    • 0020416123 scopus 로고
    • The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)
    • Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982; 31(2 Pt 1):417-427.
    • (1982) Cell , vol.31 , Issue.2 PART 1 , pp. 417-427
    • Caton, A.J.1    Brownlee, G.G.2    Yewdell, J.W.3    Gerhard, W.4
  • 35
    • 0019827545 scopus 로고
    • Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies
    • Gerhard W, Yewdell J, Frankel ME, Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981; 290:713-717.
    • (1981) Nature , vol.290 , pp. 713-717
    • Gerhard, W.1    Yewdell, J.2    Frankel, M.E.3    Webster, R.4
  • 36
    • 77649151800 scopus 로고    scopus 로고
    • Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses
    • Krause JC, Tumpey TM, Huffman CJ et al. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol 2010; 84:3127-3130.
    • (2010) J Virol , vol.84 , pp. 3127-3130
    • Krause, J.C.1    Tumpey, T.M.2    Huffman, C.J.3
  • 37
    • 84876465359 scopus 로고    scopus 로고
    • World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Available at (Accessed 13 Junel 2012).
    • World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Available at http://www.who.int/influenza/vaccines/virus/recommendations/201202_recommendation.pdf (Accessed 13 Junel 2012).
  • 38
    • 80053986744 scopus 로고    scopus 로고
    • Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties
    • Strengell M, Ikonen N, Ziegler T, Julkunen I. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties. PLoS ONE 2011; 6:e25848.
    • (2011) PLoS ONE , vol.6
    • Strengell, M.1    Ikonen, N.2    Ziegler, T.3    Julkunen, I.4
  • 39
    • 77956625295 scopus 로고    scopus 로고
    • Adaptation of pandemic H1N1 influenza viruses in mice
    • Ilyushina NA, Khalenkov AM, Seiler JP et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol 2010; 84:8607-8616.
    • (2010) J Virol , vol.84 , pp. 8607-8616
    • Ilyushina, N.A.1    Khalenkov, A.M.2    Seiler, J.P.3
  • 40
    • 78449245226 scopus 로고    scopus 로고
    • Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?
    • Ye J, Sorrell EM, Cai Y et al. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?PLoS Pathog 2010; 6:e1001145.
    • (2010) PLoS Pathog , vol.6
    • Ye, J.1    Sorrell, E.M.2    Cai, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.